Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Moderna stock jumps as pipeline progress and flu shot data lift sentiment
03:51pm, Thursday, 02'nd Jul 2026
Moderna Inc. (MRNA) shares rose 9.2% on Thursday, making the biotechnology company among the top performers in the S&P 500 as investors responded positively to new pipeline updates, encouraging influe
Short Squeeze Alert—Moderna Stock Surges on New Strategy
07:00am, Wednesday, 01'st Jul 2026
At that time, Moderna revealed its strategy for using mRNA to combat cancer and rare diseases. It's a move beyond vaccines, and investors seem to like it.
Is Moderna Stock a No-Brainer Buy After a Key FDA Win?
02:15pm, Tuesday, 30'th Jun 2026
On June 16, Moderna announced major news regarding one of its most highly anticipated follow-up products: an mRNA-based flu vaccine. The biotech company has also made some other promising announcement
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines
02:06pm, Monday, 29'th Jun 2026
Moderna hit a 52-week high after it unveiled a strategy to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and AI-driven R&D.
Stock Of The Day: Will The Moderna Rally Continue?
10:03am, Monday, 29'th Jun 2026
Moderna, Inc. (NASDAQ:MRNA) shares are trading higher on Monday. This follows Friday's gain of more than 12%.
Moderna stock soars as cancer pipeline and CAR-T push ignite optimism
02:47pm, Friday, 26'th Jun 2026
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about 40% over the past month and significantly outperformed the broader market. The gains
Moderna Is Up 13% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?
12:01pm, Friday, 26'th Jun 2026
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending a remarkable run for the mRNA pioneer.
Why Moderna Stock Is Soaring and Leading the S&P 500 Today
11:36am, Friday, 26'th Jun 2026
Moderna shares pace toward their highest close since late 2024 after unveiling a new cell therapy program.
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
07:00am, Friday, 26'th Jun 2026
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.com, a leading investment platform for retail investors
This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst
01:00am, Friday, 26'th Jun 2026
It's not just a "pandemic stock," after all.
Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript
09:32pm, Thursday, 25'th Jun 2026
Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript
Moderna Science Day Highlights Expanding Potential of mRNA Platform
07:00am, Thursday, 25'th Jun 2026
Provides broad overview of Company's research and early development programs expected to continue to fuel future growth Highlights validation of T-cell engager modality with mRNA-2808 in multiple myel
Moderna (MRNA) Rises As Market Takes a Dip: Key Facts
06:51pm, Tuesday, 23'rd Jun 2026
Moderna (MRNA) closed at $61 in the latest trading session, marking a +2.79% move from the prior day.
Major Indexes Continue Lower as Chip Selloff Drags Nasdaq
12:18pm, Tuesday, 23'rd Jun 2026
Stocks are continuing lower amid the global tech selloff, with the Nasdaq Composite (IXIC) off nearly 500 points
Should You Buy Moderna Before Aug. 5?
06:10pm, Monday, 22'nd Jun 2026
Investors flocked to Moderna during early pandemic days as its coronavirus vaccine delivered blockbuster revenue. Since, times have been tough for Moderna, but the company may have reached an importan
